A Multicenter, Phase 2 Study of Tesetaxel plus Three Different PD-(L)1 Inhibitors in Patients with Triple-Negative, Locally Advanced or Metastatic Breast Cancer and Tesetaxel Monotherapy in Elderly Patients with HER2 Negative, Locally Advanced or Metastatic Breast Cancer

  • Sabanathan, Dhanusha, (Primary Chief Investigator)
  • Park, John (Associate Investigator)
  • Gilchrist, Jenny, (Associate Investigator)
  • Rai, Meenal, (Clinical Trial Unit Staff)
  • Chapman, Nicola, (Clinical Trial Unit Staff)

Project: Research

Project Details

Short titleODO-TE-B202
AcronymCONTESSA
StatusActive
Effective start/end date1/05/2031/12/21